Back to Search Start Over

Early Weight Loss Responders to Liraglutide 3.0 mg had Greater Weight Loss, Regression to Normoglycemia and Reduced T2D Development at 3 Years vs. Early Non-Responders: SCALE Obesity and Prediabetes

Tools

Authors Abstract Subjects Details